THE RELEVANCE TO CLINICAL OUTCOMES AND RISK FACTORS OF PERI-CONTRAST STAINING (PSS) AFTER SECOND GENERATION DES DEPLOYMENT

Several studies showed peri-contrast staining (PSS) after silorimus-eluting stent was be associated with target-lesion revascularization (TLR) and very late stent thrombosis. However, the incidence and clinical sequela of PSS after second generation DES implantation are unclear, so we